Ishizawa Kenichi | 東北大学 血液･免疫病学分野
スポンサーリンク
概要
関連著者
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Seto M
Department Of Hematology And Chemotherapy
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Tobinai Kensei
東海大学 医学部
-
KAMEOKA Junichi
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
IGARASHI Tadahiko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Minami Hironobu
名古屋第一赤十字病院
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Onishi Yasushi
Department Of Biostatistics School Of Public Health University Of Tokyo
-
Seto Masao
愛知県がんセンター研究所 分子腫瘍学部
-
SASAKI Yasutsuna
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
HARIGAE HIDEO
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
Minami Hironobu
National Cancer Center Hospital East
-
TSUBOI Akihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OKA Yoshihiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
FUJII Hirofumi
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
Soma Toshihiro
大阪大学 医学系研究科
-
KAWASE Ichiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
HOSEN Naoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
Kami Masahiro
Jr東京総合病院 血液内科
-
TAWARA Masayuki
Nagasaki CML Study Group
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
Sasaki Takeshi
Department of Rheumatology, Tohoku University school of Medicine
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
KAWAKAMI Manabu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MUKUBO Masaaki
Yodogawa Christian Hospital
-
MURAKAMI Masaki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
Nakamura S
Department Of Pathology Nagoya University School Of Medicine
-
Nakamura Shigeo
国立がんセンター中央病院 血液内科
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
MIYAMURA Koichi
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
YAMADA MINAMI
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
TSURUTA Kazuto
the Department of Laboratory Midicine
-
MASUDA Tomoki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
NISHIDA Sumiyuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
CHOU Takaaki
Department of Internal Medicine, Niigata Cancer Center Hospital
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
谷脇 雅文
高知工科大学工学部
-
Yoshida S
Chiba University
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
FUJIWARA TOHRU
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
KINOSHITA Tomohiro
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OGAWA Hiroyasu
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
IKEGAME Kazuhiro
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
斉藤 広信
福島県立医科大学 医学部内科学第二講座
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
Kato Tomoyuki
愛知県がんセンター研究所 疫学予防部
-
KAKU Mitsuo
Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Gra
-
KODAMA KEN
Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases
-
OHNO Ryuzo
Aichi Cancer Center
-
永井 正
自治医科大学内科学講座血液学部門
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学(整形外科)
-
TAKAMI Akiyoshi
Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medicine
-
KAMI Masahiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Ohashi Yasuo
Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences a
-
ISHIKAWA IZUMI
Department of Internal Medicine, Osaki Citizen Hospital
-
KOHATA KATSURA
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
Saito Y
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
ICHIMURA Kouichi
Department of Pathology, Okayama University Medical School and Graduate School of Medicine, Dentistr
-
TERAUCHI Takashi
Screening Technology and Development Division, Research Center for Cancer Prevention and Screening,
-
吉川 秀樹
大阪大学大学院医学系研究科器官制御外科学
-
HIRANO Masami
Department of Hematology, Fujita Health University School of Medicine
-
KASAI Masaharu
Department of Hematology, Sapporo Hokuyu Hospital
-
OHNISHI Kazunori
Department of Internal Medicine, Hamamatsu University School of Medicine
-
永井 正
自治医科大学 内科学講座血液学部門
-
Yoshida Shigeaki
国立がんセンター東病院 消化管内科
-
Osaki Koichi
九州厚生年金病院
-
SEKINE Ikuo
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital
-
TANIGAWARA Yusuke
Department of Pharmacy, School of Medicine, Keio University
-
SAITO Yasushi
Chiba University
-
Yamada Takashi
Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima Uni
-
AOZASA Katsuyuki
Department of Pathology, Osaka University Graduate School of Medicine
-
UEDA Ryuzo
Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sci
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
OKADA Masaya
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
UTSUNOMIYA Atae
Department of Hematology, Imamura Bun-in Hospital
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
SATO Hitoshi
Department of Clinical and Molecular Pharmacokinetics/Pharmacodynamics, School of Pharmaceutical Sci
-
YOSHIKAWA Hideki
Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
-
SUZUKI Yoshihiko
Suzuki clinic
-
Ishii Tomonori
Department of Rheumatology, Tohoku University school of Medicine
-
Tsukamoto Norifumi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
TSUCHIYA Takahide
Department of Hematology and Oncology, Tokai University School of Medicine
-
Saito Y
Division Of Cardiovascular Medicine Kumamoto University Graduate School Of Medical Sciences
-
Yokota Asumi
大阪大学 医系研究 病態生体情報学
-
Yokota Asumi
Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine
-
TSUCHIYA SHIGERU
Department of Pediatrics, Tohoku University Graduate School of Medicine
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
Saito Yoshiro
国立医薬品食品衛生研究所
-
MIZOGUCHI Yoshikazu
Departments of Pathology, Fujita Health University School of Medicine
-
Saisho-hattori Takako
宮城県立こども病院 血液腫瘍科
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
Takahashi Shori
Dep. Of Pediatrics Nihon Univ. School Of Medicine
-
Takahashi Shori
東北大学 医学系研究科小児病態学分野
-
Totsune Kazuhito
東北大学 臨床薬学
-
Tokunaga Katsushi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
OKADA Hiroyuki
Department of Gastroenterology/Hepatology, Okayama University Medical School and Graduate School of
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Minami Hironobu
Division Of Oncology/hematology National Cancer Center Hospital East
-
TAMAKI Hiroya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
YAMAGAMI Tamotsu
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
KIM Eui
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
MISHIMA Machiko
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
SOMA Toshihiro
Department of Medicine, National Hospital Organization Osaka Minami Medical Center
-
FUJIOKA Tatsuya
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
TANIGUCHI Yuki
Department of Molecular Medicine, Osaka University Graduate School of Medicine
-
OSUMI Kazuoki
Otsuka Pharmaceutical Co. Ltd.
-
IKEGAME Kazuhiro
Molecular Medicine
-
TAKIMOTO Takayuki
Molecular Medicine
-
TAKAHASHI Ryo
Molecular Medicine
-
MURAKAMI Masaki
Molecular Medicine
-
TAMAKI Hiroya
Molecular Medicine
-
FUJIOKA Tatsuya
Molecular Medicine
-
KAWAKAMI Manabu
Molecular Medicine
-
HIRABAYASHI Norio
Department of Pathology, Nagoya First Red Cross Hospital
-
SOMA Toshihiro
Molecular Medicine
-
SUGIYAMA Haruo
Clinical Laboratory Science, Osaka University Medical School
-
OGAWA Hiroyasu
Clinical Laboratory Science, Osaka University Medical School
-
ASADA Momotaro
Department of Clinical Laboratory Science, Osaka University Medical School
-
SUZUKI Ritsuro
Department of HSCT Data Management, Nagoya University Hospital
-
YOSHIMURA Kenichi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
OKAMOTO Rumiko
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
ASAOKU Hideki
Clinical Laboratory, Hiroshima Red Cross Hospital, Atomic-Bomb Survivors Hospital
-
KUROSAWA Mitsutoshi
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center
-
MAEDA Yoshiharu
Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospi
-
OMACHI Ken
Department of Hematology and Oncology, Tokai University School of Medicine
-
TAKAYAMA Nobuyuki
Second Department of Internal Medicine, Kyorin University
-
KABA Harumi
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
YAMAMOTO Seiichiro
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
FUKUDA Haruhiko
Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, N
-
KIKUCHI Masahiro
Department of Pathology, School of Medicine, Fukuoka University
-
HOTTA Tomomitsu
National Hospital Organization, Nagoya Medical Center
-
ENDO Keigo
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicin
-
SETO Masao
Laboratories of Chemotherapy and Immunology, Aichi Cancer Research Institute
-
Aizawa Tetsushi
Tochigi Cancer Center
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
YATABE Yasushi
Department of Pathology and Molecular Diagnosis, Aichi Cancer Center Central Hospital
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
TANIGUCHI Shuichi
Department of Hematology, Toranomon Hospital
-
JINNAI Itsuro
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
Ando Kiyoshi
Division of Hematology and Oncology, Tokai University School of Medicine
-
SAKAMAKI Hisashi
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
MORI Takehiko
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
YOSHIDA Takashi
Hematology Department, Toyama Prefectural Hospital
-
Seino Yoshihiko
Department Of Internal Medicine Cardiovascular Center Nippon Medical School Chiba-hokusoh Hospital
-
UCHIYAMA-KOKUBU Noriko
Tsukuba Research Institute, Novartis Pharma K.K.,
-
AIZAWA Tetsushi
Tsukuba Research Institute, Novartis Pharma K.K.,
-
WATANABE Toru
Tsukuba Research Institute, Novartis Pharma K.K.,
-
UDA Yoshinori
Tsukuba Research Institute, Novartis Pharma K.K.,
-
HARADA Mine
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences
-
Saijo Nagahiro
Pharmacology Division, National Cancer Center Research Institute
-
SHICHISHIMA Tsutomu
Department of Cardiology and Hematology, Fukushima Medical University
-
TAKAHASHI Naoto
Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine
-
NOJI Hideyoshi
Department of Cardiology and Hematology, Fukushima Medical University
-
Harada M
Department Of Hematology-oncology Ehime Prefectural Central Hospital
著作論文
- Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
- A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
- WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
- Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
- The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
- Photo-Induced Reactions of Oxime O-Ethers Derived from 3-Acyl-1, 2-dihydrocinnoline- 1, 2-dicarboximides
- Novel Photo-Rearrangement of Oxime Methyl Ethers of 3-Acyl-1, 2dihydrocinnoline-N-phenyl-1, 2-dicarboximides
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
- Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
- Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
- Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
- Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Orbital MALT Lymphoma, Abdominal Hodgkin lymphoma, and Systemic Diffuse Large B-cell Lymphoma Develop Sequentially in One Patient
- Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95